Overview

A leading global ophthalmic organization was evaluating opportunities to enhance the experience of its ophthalmic viscosurgical device, with a specific focus on understanding how cataract surgeons perceive single-syringe and twin-pack OVD systems. This ophthalmic viscosurgical device research cataract surgery insights initiative was designed to support stronger product strategy through real-world physician insights and specialist feedback.

The research was designed to uncover the key drivers behind OVD utilization, identify perceived gaps between all-in-one formulations and twin-pack systems, and determine what product experience improvements would be needed to motivate conversion from twin-pack usage to a single-syringe solution. As an OVD product evaluation and surgeon preference study, it explored both functional product perceptions and broader surgeon preferences influencing usage decisions.

The study engaged cataract surgeons across the United States, Italy, Canada, and Japan, ensuring a balanced global perspective from qualified ophthalmologists with hands-on experience using relevant OVD products in cataract surgery. This multi-market approach supported cataract research, ophthalmology insights, and OVD research by capturing how surgeon perceptions vary across global healthcare settings.

Business Challenge

The organization’s global team was reformulating an established OVD product and wanted to use this opportunity to better understand how surgeons evaluate clinical utility, product performance, convenience, and overall surgical experience. The work supported broader medical device research and healthcare market research needs by identifying how product experience influences clinical and purchasing considerations.

A key business objective was to determine what would encourage current twin-pack users to adopt or convert to a single-syringe system. This required understanding not only the benefits surgeons already associated with the single-syringe product, but also the reasons why many continued to value or prefer twin-pack alternatives. As a single syringe vs twin pack OVD adoption study, the research provided important cataract surgery product conversion drivers and ophthalmic device adoption barriers and conversion insights.

The study also needed to capture nuanced market differences across four countries, including product familiarity variations in Japan, where surgeons were required to have experience with relevant OVD products. The target audience was highly specialized, requiring strict screening criteria around clinical role, surgical volume, decision-making authority, product experience, and professional independence. This made the project a focused surgeon behavior study on ophthalmic device adoption and a valuable example of clinical decision making in cataract surgery product research.

Our Approach

We designed and supported a structured quantitative research approach among cataract surgeons in the US, Italy, Canada, and Japan, with a total target sample of 240 respondents evenly distributed across the four markets. This quantitative research for cataract surgeons product perception study was built to generate reliable, comparable healthcare insights across diverse healthcare environments.

Respondents were carefully screened to ensure they were currently employed in ophthalmology, spent the majority of their professional time in clinical practice, had meaningful cataract surgery volume, and were involved in the decision-making, recommendation, or influence of surgical product and device purchasing. This enabled a robust surgeon behavior analysis focused on actual product use, evaluation, and influence.

To protect data quality and ensure respondent relevance, participation was limited to surgeons who agreed to confidentiality and intellectual property requirements, met market-specific board certification or surgical volume criteria, and had direct experience with the required OVD products in their respective markets. This strengthened the study as both a surgical device study and device evaluation research initiative among qualified clinical decision-makers.

Results

The study successfully delivered a balanced global sample of cataract surgeons across four key markets, enabling the organization to compare product perceptions, adoption barriers, and benefit valuation across different healthcare environments. These ophthalmology market research OVD usage insights helped clarify how surgeons think about product performance, convenience, and clinical utility in real-world cataract surgery settings.

The research helped identify the most valued benefits associated with single-syringe and twin-pack OVD systems, while also clarifying what would need to be true for surgeons to increase adoption of, or convert to, the single-syringe option. This delivered meaningful OVD single syringe benefits and adoption analysis and supported broader product adoption research around OVD usage behavior.

By quantifying the value associated with specific product benefits, the study provided the organization with actionable insight into the product attributes, experience improvements, and communication priorities most likely to influence future utilization behavior among cataract surgeons. The findings offered practical surgical device utilization and experience insights to guide future product positioning, communication priorities, and engagement strategy. They also supported broader healthcare B2B research ophthalmology product strategy insights by clarifying which product attributes and experience improvements were most likely to influence surgeon behavior.

For organizations seeking to evaluate specialist physician perceptions, product adoption barriers, or conversion opportunities across global healthcare markets, our research capabilities help deliver high-quality, targeted insights from hard-to-reach clinical audiences. This cataract surgery device innovation and surgeon feedback study demonstrates how a targeted medical insights study and healthcare B2B insights approach can inform product development, messaging, and adoption strategy. Contact Xcel Global Panel to get started.